Results 351 to 360 of about 12,260,572 (400)

Sex-specific high-sensitivity troponin T cut-points have similar safety but lower efficacy than overall cut-points in a multisite U.S. cohort. [PDF]

Acad Emerg Med
Montgomery CM, Ashburn NP, Snavely AC, Allen B, Christenson R, Madsen T, McCord J, Mumma B, Hashemian T, Supples M, Stopyra J, Wilkerson RG, Mahler SA.   +12 more
europepmc   +1 more source

Cardiac troponin T (cTnT) assessment using incompletely filled K2EDTA blood tubes is reliable. [PDF]

Einstein (Sao Paulo)
Lippi G, Salvagno GL.
europepmc   +1 more source

Structure predictions of MuRF1‐UBE2 complexes identify amino acid residues governing interaction selectivity for each MuRF1‐E2 pair

The FEBS Journal, EarlyView.
MuRF1 is a major regulator of muscle atrophy, a side effect of chronic pathologies. As a RING‐type E3, MuRF1 depends on E2 enzymes to synthesize ubiquitin chains on substrates. MuRF1 can interact with four E2 enzymes, suggesting different physiological functions depending on the MuRF1‐E2 pair.
Agnès Claustre, Mélodie Malige, Maëlys Macheton, Lydie Combaret, Etienne Lefai, Pierre Fafournoux, Daniel Taillandier, Julien Henri, Cécile Polge   +8 more
wiley   +1 more source

Performance of D-dimer, cardiac troponin T, C-reactive protein, and NT-proBNP in prediction of long-term mortality in patients with suspected pulmonary embolism. [PDF]

Eur Heart J Open
Kauppi J, Airaksinen KEJ, Lehto J, Pouru JP, Saha J, Purola P, Jaakkola S, Lehtonen J, Vasankari T, Juonala M, Kiviniemi T.   +10 more
europepmc   +1 more source

Survivorship following myocardial infarction in a contemporary Australian cohort: defining cardiac versus non‐cardiac mortality

Internal Medicine Journal, EarlyView.
Abstract Background and Aims Progress in the management of myocardial infarction (MI) has led to reductions in cardiac mortality. The aim of this study was to describe the temporal trends in the relative proportions of cardiac death (CD) and non‐cardiac death (NCD) in an Australian cohort with MI following in‐hospital stay, then at 6 and 12 months as ...
James Nguyen, Nicole Chan, Christopher Hammett, Peter Stewart, William Vollbon, Michael Mallouhi, John J. Atherton, Sandhir B. Prasad   +7 more
wiley   +1 more source

Differences in Troponin I and Troponin T Release in High-Performance Athletes Outside of Competition. [PDF]

Int J Mol Sci
Wuestenfeld JC, Kastner T, Hesse J, Fesseler L, Frohberg F, Rossbach C, Wolfarth B.   +6 more
europepmc   +1 more source

Advancing evidence‐based practice through the Knowledge Translation Challenge: Nurses’ important roles in research, implementation science and practice change

Journal of Advanced Nursing, EarlyView.
Abstract Aim To describe a knowledge translation capacity‐building initiative and illustrate the roles of nurses in practice change using an exemplar case study. Design The report uses observational methods and reflection. Methods The Knowledge Translation Challenge program involves a multi‐component intervention across several sites.
Amanda Chisholm, Angela Russolillo, Michelle Carter, Marla Steinberg, Leah Lambert, Andrea Knox, Agnes Black   +6 more
wiley   +1 more source

Prognostic Value and Determinants of High-Sensitivity Cardiac Troponin T in Patients With a Systemic Right Ventricle: Insights From the SERVE Trial. [PDF]

J Am Heart Assoc
Ruperti-Repilado FJ, Tran F, Haaf P, Lopez-Ayala P, Greutmann M, Schwerzmann M, Bouchardy J, Gabriel H, Stambach D, Rutz T, Schwitter J, Wustmann K, Freese M, Mueller C, Tobler D.   +14 more
europepmc   +1 more source

High‐sensitivity cardiac troponin after cardiac stress test: A systematic review and meta‐analysis [PDF]

, 2019
Avila, Audrey, Ben Abdallah, Arbi, Helwani, Mohammad A, Jaffe, Allan S, Nagele, Peter, Samaha, Eslam, Scott, Mitchell G   +6 more
core   +1 more source

Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and Management

Journal of Cardiovascular Electrophysiology, EarlyView.
To improve arrhythmogenic cardiomyopathy (ACM) patient care four pillars of ACM research are necessary. The first pillar to improve ACM is cohort studies in which the genotype‐specific natural history of disease is described, and subsequently genotype‐specific risk calculators can be developed, such as the DSP and PLN risk calculators.
Steven A. Muller, Giorgia Bertoli, Jianan Wang, Alessio Gasperetti, Moniek G. P. J. Cox, Hugh Calkins, Anneline S. J. M. te Riele, Daniel P. Judge, Mario Delmar, Richard N. W. Hauer, Gerard J. J. Boink, Marina Cerrone, J. Peter van Tintelen, Cynthia A. James   +13 more
wiley   +1 more source